INBIONET, acronym standing for “INfection BIOlogy Training NETwork”, at the interface between microbiology, immunology and cellular biology, aims to explore some of the most novel themes that are beginning to emerge in the mechanisms by which pathogens manipulate host defence responses. Further, it is expected that this knowledge will lead to the development of innovative therapies based on the modulation of the host-pathogen interface.


The project is funded under the Marie Curie Initial Training Network scheme (ITN) as part of the EU’s Seventh Framework Programme (FP7) and will run from the 1st of January 2013 to 31st of December 2016. During the 4-year duration of the project a total of 15 fellows will receive training in all areas of infection biology research.


The Network integrates seven academic groups internationally recognized in the fields of microbial pathogenesis, innate immunity and molecular recognition, and intensive research SME, Preclin Biosystems, a multinational pharmaceutical company, Sanofi-Aventis, and is further supported by one associated partner (ParcBit, technological part).

Outreach & News

What is a molecular microbiologist?

Kora Przybyszewska endeavours to define the role of a "Molecular Microbiologist"

Read more

Microbiota, colibactin and colon cancer: a snaphot

Barbara Corelli takes a brief look at Microbiota, colibactin and colon cancer in this, her final INBIONET report.

Read more

Microcins can act as therapeutics to treat enterobacterial colitis.

Barbara Corelli reviews the recent study by M. Sassone-Corsi et al. "Microcins mediate competition among Enterobacteriaceae in the inflamed gut." published in "Nature" 540, 280–283 (2016).


Read more

Innate and adaptive immune system

Filipe Lopes De Vasconcelos gives a brief overview of the innate and adaptive immune system in this short report.

Read more